Lüscher, Thomas F.

Thomas F. Lüscher

Zürich, Switzerland

Training and Current Position

Professor Lüscher studied medicine at the Univer-sity of Zurich and obtained the Swiss board certi-fication in internal medicine and cardiology. He trained in cardiovascular research and in cardio-l-gy at the Mayo Clinic in Rochester, MN, USA and was later Professor of Pharmacotherapy at the University of Basel, then trained in interventional cardiology and was nominated Professor of Car-diology at the University of Berne, before assu-ming a position as Professor and Chairman of Car-diology and Director of the University Heart Center at the University Hospital Zurich and Director of the Center for Molecular Cardiology at the Univer-sity of Zurich, Switzerland. He is now Director of Research, Education & Development and Con-sulting Cardiologist at the Royal Brompton & Hare-field Hospital Trust and Professor of Cardiology at the National Heart and Lung Institute of Imperial College and at Kings College in London, United Kingdom.


Clinical Competence and Activity

Professor Lüscher is an active general and interventional cardiologist with a broad clinical scope and large experience in prevention, coronary and valvular heart disease, percutaneous interventions and heart failure.



Professor Lüscher has been a mentor of numerous young physicians and scientists from around the world. His research is translational in nature and focuses on vascular disease, specifically on the endothelium in the regulation of vascular tone and structure, platelet-vessel wall interactions, inflammation and coagulation. His team has characterized the effects of aging, hypertension, lipid disorders and atherosclerosis on endothelial function both experimentally and clinically. More recently, inflammatory pathways in acute coronary syn-dromes has been at the center of interest. He has published extensively, original research articles, reviews, editorials, book chapters and monographs including the ESC Textbook of Cardiovascular Medicine, Oxford University Press.


Recognition and Awards

By the Institute for Scientific Information he has been rated as one of the 0.5% most cited scientists worldwide (current h-Index 133; Scope). He has obtained numerous research prizes and prestigious lecturerships worldwide.

He is a member of many editorial boards and was Associate Editor Europe of Circulation from 2004 to 2008 and editor-in-chief of the European Heart Journal and chairman of the ESC Publications Committee from 2009-2020. Beforehand, he has served the European Society of Cardiology as chairman of the congress programme committee and vice-president of the working groups and now holds the position of Secretary/Treasurer in the ESC Management Committee.



Wednesday 02 June

Atherosclerosis management: will the future look smarter?


Share this: